{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:22:00Z","timestamp":1788175320542,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jjcc.2017.03.001","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T21:49:39Z","timestamp":1489873779000},"page":"128-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease"],"prefix":"10.1016","volume":"70","author":[{"given":"Katsuya","family":"Onishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2017.03.001_bib0165","series-title":"Management and Prevention of COPD","author":"The Global Strategy for the Diagnosis","year":"2017"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0170","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0175","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(11)60988-4","article-title":"New insights into the immunology of chronic obstructive pulmonary disease","volume":"378","author":"Brusselle","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0180","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S2213-2600(16)00097-7","article-title":"Management of chronic obstructive pulmonary disease beyond the lungs","volume":"4","author":"Vanfleteren","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0185","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","article-title":"Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"3","author":"Chen","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0190","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2147\/COPD.S59962","article-title":"Prevalence of airflow limitation in outpatients with cardiovascular diseases in Japan","volume":"9","author":"Onishi","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0195","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1164\/rccm.201306-1170OC","article-title":"Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease","volume":"188","author":"Patel","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0200","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1378\/chest.11-0853","article-title":"The impact of ischemic heart disease on symptoms, health status, and exacerbations in patients with COPD","volume":"141","author":"Patel","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0205","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1513\/pats.200404-032MS","article-title":"Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality","volume":"2","author":"Sin","year":"2005","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0210","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.rmed.2009.09.016","article-title":"Systemic and airway inflammation and the presence of emphysema in patients with COPD","volume":"104","author":"Papaioannou","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0215","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1042\/CS20160043","article-title":"COPD and stroke: are systemic inflammation and oxidative stress the missing links?","volume":"130","author":"Austin","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0220","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/thx.2010.157529","article-title":"Increased platelet activation in patients with stable and acute exacerbation of COPD","volume":"66","author":"Maclay","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0225","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/eurheartj\/ehv121","article-title":"Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study","volume":"36","author":"Lahousse","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0230","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1183\/09031936.03.00051502","article-title":"Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study","volume":"21","author":"Buch","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0235","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/thoraxjnl-2011-201275","article-title":"Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications","volume":"68","author":"Singh","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0240","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1253\/circj.CJ-09-0254","article-title":"Characteristics and outcomes of hospitalized patients with heart failure and reduced vs preserved ejection fraction. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD)","volume":"73","author":"Tsuchihashi-Makaya","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0245","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.trsl.2013.05.001","article-title":"Chronic obstructive pulmonary disease and cardiovascular disease","volume":"162","author":"Bhatt","year":"2013","journal-title":"Transl Res"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0250","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1378\/chest.128.4.2068","article-title":"COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program","volume":"128","author":"Sidney","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0255","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jjcc.2014.02.003","article-title":"Cardiovascular function and prognosis of patients with heart failure coexistent with chronic obstructive pulmonary disease","volume":"64","author":"Yoshihisa","year":"2014","journal-title":"J Cardiol"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0260","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/ehjci\/jet131","article-title":"Myocardial perfusion reserve is impaired in patients with chronic obstructive pulmonary disease: a comparison to current smokers","volume":"15","author":"Nakamori","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0265","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1093\/eurheartj\/eht192","article-title":"Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services","volume":"34","author":"Hawkins","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0270","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0735-1097(01)01744-2","article-title":"Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea","volume":"39","author":"Morrison","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0275","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jacc.2011.02.020","article-title":"Heart failure and chronic obstructive pulmonary disease the quandary of beta-blockers and beta-agonists","volume":"57","author":"Hawkins","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0280","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"A 4-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0285","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa1008378","article-title":"Tiotropium versus salmeterol for the prevention of exacerbations of COPD","volume":"364","author":"Vogelmeier","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0290","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/thorax.58.7.556","article-title":"ACE in COPD: a therapeutic target?","volume":"58","author":"Forth","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0295","series-title":"Global Strategy for Asthma Management and Prevention","author":"Global Initiative for Asthma","year":"2017"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0300","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jacc.2010.01.024","article-title":"Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial","volume":"55","author":"Jabbour","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0305","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1183\/13993003.01847-2015","article-title":"Beta-blockers in COPD: time for reappraisal","volume":"48","author":"Lipworth","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0310","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","author":"MERIT-HF Study Group","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0315","doi-asserted-by":"crossref","first-page":"d2549","DOI":"10.1136\/bmj.d2549","article-title":"Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study","volume":"342","author":"Short","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jjcc.2017.03.001_bib0320","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijcard.2013.10.068","article-title":"Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study","volume":"170","author":"Tavazzi","year":"2013","journal-title":"Int J Cardiol"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508717300552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508717300552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:56:59Z","timestamp":1760273819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508717300552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0914508717300552"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2017.03.001","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2017.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}